Clinical Trial Update: Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial)

View source ↗

Summary

The CHAS3 trial is validating the Stockholm3 diagnostic test in men with prostate cancer on active surveillance in Switzerland, and recruitment has not yet begu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Prostate Cancer, Active Surveillance for Prostate Cancer | Status: NOT_YET_RECRUITING